Regenxbio INC DEF 14A proxy statements

REGENXBIO Inc. announced its 2026 Annual Meeting of Stockholders, scheduled for May 29, 2026, to elect directors, ratify auditor selection, and vote on executive compensation and stock option exchange proposals.

REGENXBIO Inc. has filed a definitive proxy statement with the SEC.

REGENXBIO Inc. has released its proxy statement for the upcoming Annual Meeting of Stockholders to be held on May 30, 2025, outlining key proposals including the election of directors, ratification of the accounting firm, and approval of the 2025 Equity Incentive Plan.

REGENXBIO Inc. has filed a definitive proxy statement with the SEC.

REGENXBIO Inc.'s proxy statement outlines proposals for the upcoming annual meeting, including director elections, ratification of the accounting firm, and an advisory vote on executive compensation.